Lantern Pharma Inc (LTRN)
6.14
-0.19
(-3.00%)
USD |
NASDAQ |
May 16, 16:00
6.10
-0.04
(-0.65%)
Pre-Market: 20:00
Lantern Pharma Net Income (TTM): -17.53M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -17.53M |
| December 31, 2023 | -15.96M |
| September 30, 2023 | -15.16M |
| June 30, 2023 | -14.26M |
| March 31, 2023 | -14.01M |
| December 31, 2022 | -14.26M |
| September 30, 2022 | -14.42M |
| June 30, 2022 | -16.21M |
| March 31, 2022 | -14.03M |
| Date | Value |
|---|---|
| December 31, 2021 | -12.36M |
| September 30, 2021 | -11.72M |
| June 30, 2021 | -9.366M |
| March 31, 2021 | -7.883M |
| December 31, 2020 | -5.908M |
| September 30, 2020 | -3.687M |
| June 30, 2020 | -2.656M |
| March 31, 2020 | -2.452M |
| December 31, 2019 | -2.428M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-17.53M
Minimum
Mar 2024
-2.428M
Maximum
Dec 2019
-10.79M
Average
-13.18M
Median
Net Income (TTM) Benchmarks
| Eyenovia Inc | -27.26M |
| Cassava Sciences Inc | -47.90M |
| Alpine Immune Sciences Inc | -36.84M |
| Clearside Biomedical Inc | -34.97M |
| Poseida Therapeutics Inc | -108.86M |